EZH2 and cancer: Thus, telomere dysfunction induces enhancer of zeste homolog 2 (EZH2) repression by APC-deficient cancer stem cells, resulting in the derepression of WNT antagonists, hence triggering the differentiation of the neighboring normal stem cells [127].